RecallDepth
Class II Terminated

Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S Indoco Remedies Limited., L-32, 33, 34, Verna Industrial area, Verna - Goa, 403722, India; Mfd. for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-341-35.

Company
Cipla
Recall Initiated
July 14, 2022
Posted
July 27, 2022
Recall Number
D-1283-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
8,136 bottles
Firm Location
Warren, NJ, United States

Reason for Recall

Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

Distribution

Nationwide in the USA

Lot / Code Info

Batch# DEG4LC2, exp. date 05/2023

More recalls by Cipla

View all recalls by this company →

Other recent Class II Drug recalls